Marina Lasa
Madrid, MD 28029, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Molecular Determinants of Thyroid Cancer Progression: Thyroid Hormone Signaling, the BRAF/MAPK Pathway, and Emerging miRNA Biomarkers.
Journal: Biomedicines
Published: March 16, 2026
Analysis of Apoptosis by Thyroid Hormone Induction.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: November 23, 2024
Protein kinase D activity is a risk biomarker in prostate cancer that drives cell invasion by a Snail/ERK dependent mechanism.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: March 13, 2023
Thyroid hormones act as modulators of inflammation through their nuclear receptors.
Journal: Frontiers in endocrinology
Published: May 05, 2022
V600EBRAF Inhibition Induces Cytoprotective Autophagy through AMPK in Thyroid Cancer Cells.
Journal: International journal of molecular sciences
Published: May 06, 2021
Resveratrol promotes apoptosis through the induction of dual specificity phosphatase 1 and sensitizes prostate cancer cells to cisplatin.
Journal: Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association
Published: July 13, 2018
Author Correction: Excitotoxic inactivation of constitutive oxidative stress detoxification pathway in neurons can be rescued by PKD1.
Journal: Nature communications
Published: February 01, 2018
VHL promotes immune response against renal cell carcinoma via NF-κB-dependent regulation of VCAM-1.
Journal: The Journal of cell biology
Published: August 05, 2016
Last Updated: 09/26/2026